Clinician-perceived barriers to cervical cancer screening before and during the COVID-19 pandemic at three US healthcare systems

Authors

Veronica M Boratyn, Harvard University
Gaia Pocobelli, Kaiser Permanente Washington Health Research Institute
Steven J Atlas, Harvard University
Cheryl R Clark, Harvard University
Sarah Feldman, Harvard University
Gina Kruse, Harvard University
Anne Marie McCarthy, University of Pennsylvania
Meghan Rieu-Werden, Harvard University
Michelle I Silver, Washington University School of Medicine in St. Louis
Noel O Santini, University of Texas Southwestern Medical Center
Jasmin A Tiro, University of Texas Southwestern Medical Center
Jennifer S Haas, Harvard University

Journal

Preventive Medicine Reports

Publication Date

7-1-2024

Volume

43

First Page

102783

Document Type

Open Access Publication

DOI

10.1016/j.pmedr.2024.102783

Rights and Permissions

Boratyn VM, Pocobelli G, Atlas SJ, Clark CR, Feldman S, Kruse G, Marie McCarthy A, Rieu-Werden M, Silver MI, Santini NO, Tiro JA, Haas JS. Clinician-perceived barriers to cervical cancer screening before and during the COVID-19 pandemic at three US healthcare systems. Prev Med Rep. 2024 Jun 1;43:102783. doi: 10.1016/j.pmedr.2024.102783. © 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).

Recommended Citation

Boratyn, Veronica M; Pocobelli, Gaia; Atlas, Steven J; Clark, Cheryl R; Feldman, Sarah; Kruse, Gina; Marie McCarthy, Anne; Rieu-Werden, Meghan; Silver, Michelle I; Santini, Noel O; Tiro, Jasmin A; and Haas, Jennifer S, "Clinician-perceived barriers to cervical cancer screening before and during the COVID-19 pandemic at three US healthcare systems." Preventive Medicine Reports. 43, 102783 (2024).
https://digitalcommons.wustl.edu/oa_4/5256

Department

ICTS (Institute of Clinical and Translational Sciences)